Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003842818 | SCV004641434 | pathogenic | not provided | 2023-08-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ERCC8-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys157Thrfs*4) in the ERCC8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC8 are known to be pathogenic (PMID: 29572252). |
Fulgent Genetics, |
RCV005038562 | SCV005673551 | likely pathogenic | Cockayne syndrome type 1; UV-sensitive syndrome 2 | 2024-03-18 | criteria provided, single submitter | clinical testing |